It is not advised to administer the BioNTech/Pfizer and Moderna vaccine to the following groups until more research is done to ensure the highest standard of safety for these specific groups:
o Pregnant women
o Children under 16 years
All vaccines are thoroughly tested on tens of thousands of persons in medical trials before they are approved. However, the above groups were not included in the trials yet. Even though we expect it to be harmless for these groups as well, we will await the results of further research and approval for these specific groups.
The following persons should consult their family doctor in order to decide whether any vaccine is safe for them to take:
o Severe allergic (anaphylactic) reaction to a vaccine or medication in the past. Only a severe allergic reaction against any of the vaccine ingredients is a definite contra-indication.
o Persons with severe coagulation disorders or on coagulation medication, because the injection can cause bruising or bleeding.
o Immunocompromised persons:
§ Auto-immune disease patients
§ Oncology patients on chemotherapy
§ Dialysis patients
§ Patients with history of organ transplantation
§ Patients with poorly regulated diabetes
§ HIV patients
The following persons should delay their COVID-19 vaccination:
o Acute severe infection or acute febrile illness at time of the planned vaccination. These persons should delay the vaccination until symptoms have subsided. However, persons with mild infection symptoms do not need to delay.
o Current or recent confirmed COVID-19 infection. Persons who have had a COVID-19 infection are recommended to get a COVID-19 vaccine, but at least 4 weeks after onset of symptoms or positive COVID-19 test result to distinguish between infection symptoms and vaccine side effects.
o Suspected COVID-19 infection. Persons with symptoms possibly related to COVID-19 should not come to the vaccination station. They should get tested and wait for their results first. If the result is negative, you can then still get your vaccine.
o Treated with monoclonal antibodies for COVID-19. These persons should wait at least 3 months before getting the vaccine.